A double blinded, randomized trial on the effects of donor specific bone marrow infusion following heart transplantation

被引:0
|
作者
McGuri, PA
Platsoucas, CD
Ricordi, C
Slachta, CA
Goldman, BI
Fedalen, P
Gaughan, JP
Gehan, EA
Xu, B
Eisen, HJ
Furukawa, S
Jeevanandam, V
机构
[1] Temple Univ, Ctr Hlth Sci, Philadelphia, PA 19122 USA
[2] Temple Univ, Sch Med, Philadelphia, PA 19122 USA
[3] Univ Miami, Sch Med, Miami, FL 33152 USA
[4] Georgetown Univ, Washington, DC USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
952
引用
收藏
页码:184 / 184
页数:1
相关论文
共 50 条
  • [21] IMMUNOMODULATORY EFFECTS OF DONOR LYMPHOCYTE INFUSIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SOIFFER, RJ
    ALYEA, EP
    RITZ, J
    JOURNAL OF CLINICAL APHERESIS, 1995, 10 (03) : 139 - 143
  • [22] DONOR-SPECIFIC TRANSFUSION AND DONOR BONE-MARROW INFUSION IN RENAL-TRANSPLANTATION TOLERANCE - A REVIEW OF EFFICACY AND MECHANISMS
    BRENNAN, DC
    MOHANAKUMAR, T
    FLYE, MW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (05) : 701 - 715
  • [23] DONOR LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    MCCANN, SR
    LAWLER, M
    GARDINER, N
    ORIORDAN, J
    HUMPHRIES, P
    DEARCE, M
    LEUKEMIA, 1994, 8 : S133 - S136
  • [24] COMPLETE REMISSION FOLLOWING DONOR LEUKOCYTE INFUSION IN ALL RELAPSING AFTER HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION
    FERSTER, A
    BUJAN, W
    MOURAUX, T
    DEVALCK, C
    HEIMANN, P
    SARIBAN, E
    BONE MARROW TRANSPLANTATION, 1994, 14 (02) : 331 - 332
  • [25] Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion
    Harmon, JV
    Gruessner, AC
    Nakhleh, RE
    Zhang, K
    Gruessner, RWG
    ARCHIVES OF SURGERY, 2001, 136 (07) : 817 - 821
  • [26] Implementation of a large randomized prospective clinical trial in Unrelated Donor Bone Marrow (BM) Transplantation.
    Carter, SL
    Jensen, LA
    Stablein, DM
    Flomenberg, N
    Bishop, MR
    Martin, PJ
    Kernan, NA
    Wagner, JE
    Thompson, J
    Howe, C
    Geller, N
    BLOOD, 2002, 100 (11) : 468B - 468B
  • [27] Phase-I trial of combination chemotherapy and donor lymphocyte infusion for relapsed aggressive hematologic malignancies following allogeneic bone marrow transplantation.
    Mookerjee, B
    Couzi, R
    Seber, A
    Miller, C
    Noga, S
    Douglas, T
    Altomonte, V
    Gore, S
    Jones, R
    Vogelsang, G
    Fuchs, E
    BLOOD, 1999, 94 (10) : 162A - 162A
  • [28] Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation
    Kishi, Y
    Kami, M
    Oki, Y
    Kazuyama, Y
    Kawabata, M
    Miyakoshi, S
    Morinaga, S
    Suzuki, R
    Mori, S
    Muto, Y
    BONE MARROW TRANSPLANTATION, 2000, 26 (05) : 573 - 576
  • [29] Chromosomal transformation in donor cells following allogeneic bone marrow transplantation
    Z Lang
    P Dinndorf
    S Ladisch
    E Bayever
    G Reaman
    Bone Marrow Transplantation, 2004, 33 : 1253 - 1256
  • [30] Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation
    vanBekkum, DW
    KinwelBohre, EPM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (06) : 478 - 480